Vivalyx
PrivateLast Round
VC Round
Feb 19, 2025
Total Funding Raised
$10.02M
Company Overview
Vivalyx operates in Healthcare & Life Sciences and is based in Aachen. Its latest recorded funding round was a VC Round in February 2025.
Vivalyx is a biotech company that has developed a patented, blood-free preservation liquid called Omnisol for organ preservation before transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivalyx Comparables
Compare Vivalyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carnamedica Sp. z o.o. | 83% | |
| Dr. Franz Köhler Chemie GmbH | 81% | |
| Bridge to Life | 79% |
For institutional investors. Book with your work email.
Vivalyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 19, 2025 | ||||
| Grant | Feb 19, 2025 | ||||
| Seed | Apr 30, 2024 | ||||
| Pre Seed | Jun 15, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vivalyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, VC Round |
| Tech Vision Fonds | Grant, Seed |
| Arve Capital | Grant, Seed |
| GOOSE Capital | Grant, Seed |
| Brightlands Venture Partners | Grant, Seed |
| Angel Invest | Grant, Pre Seed, Seed |
| Angel Invest | Pre Seed, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Hiring Head of Production for Omnisol's European launch.
- Feb 19, 2025
Secured $2.69M in grant funding.
For institutional investors. Book with your work email.
Vivalyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivalyx's valuation, stock price, and market status.
Is Vivalyx a public or private company?
Vivalyx is a private company.
What is the current stock price of Vivalyx?
Vivalyx is a private company, so its shares have no public market price. Caplight tracks Vivalyx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivalyx worth (valuation)?
Valuation information for Vivalyx is not publicly available.
Can I buy Vivalyx stock?
Vivalyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivalyx's last funding round?
Vivalyx's most recent funding round was VC Round on February 19, 2025.
Who are the main investors in Vivalyx?
Key investors in Vivalyx include Tech Vision Fonds, Brightlands Venture Partners, EIC Fund.
Will Vivalyx IPO soon?
No public IPO plans have been announced for Vivalyx.
How can I track Vivalyx secondary market activity?
Caplight tracks bids, offers, and trades in Vivalyx's shares on secondary markets.